Your email has been successfully added to our mailing list.

×
-0.0173410404624278 -0.0173410404624278 -0.0173410404624278 -0.0173410404624278 -0.0173410404624278 -0.0173410404624278 -0.0173410404624278 -0.0173410404624278
Stock impact report

Qualigen Therapeutics announces management changes Sep. 26, 2024 5:28 PM ET By: Akanksha Khushi , SA News Editor [Seeking Alpha]

Qualigen Therapeutics, Inc. (QLGN) 
Company Research Source: Seeking Alpha
as chief executive officer and chairman of the company, effective immediately. CFO, Christopher Lotz has also tendered his resignation. Both resignations were due to disagreements with the company regarding its future direction and strategic initiatives. Qualigen Therapeutics ( QLGN ) has appointed Campbell Becher as President, and Kevin Richardson as interim CEO and CFO, effective immediately. Recommended For You More Trending News About QLGN Stock Related Stocks Trending Analysis Trending News Show less Read more
Impact Snapshot
Event Time:
QLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for QLGN alerts
Opt-in for
QLGN alerts

from News Quantified
Opt-in for
QLGN alerts

from News Quantified